<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://teaching.ncl.ac.uk/bms/wiki//api.php?action=feedcontributions&amp;feedformat=atom&amp;user=130300885</id>
	<title>The School of Biomedical Sciences Wiki - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://teaching.ncl.ac.uk/bms/wiki//api.php?action=feedcontributions&amp;feedformat=atom&amp;user=130300885"/>
	<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki/index.php/Special:Contributions/130300885"/>
	<updated>2026-04-13T14:08:34Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Trastuzumab&amp;diff=11967</id>
		<title>Trastuzumab</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Trastuzumab&amp;diff=11967"/>
		<updated>2014-11-25T10:28:41Z</updated>

		<summary type="html">&lt;p&gt;130300885: Created page with &amp;quot;&amp;amp;nbsp;Trastuzumab, known more commonly as Herceptin, is a medicine used to treat some breast and stomach cancers. The human epidermal growth factor r...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;amp;nbsp;Trastuzumab, known more commonly as Herceptin, is a medicine used to treat some [[Breast Cancer|breast]] and stomach [[Cancer|cancers]]. The human epidermal growth factor receptor 2 is a [[Protein|protein]] present in ordinary human cells. The levels of this protein are abnormally high in [[Cancer|cancer]] patients; therefore they are known as HEF2 positive.&amp;amp;nbsp;&amp;lt;ref&amp;gt;NHS choices,2014,Herceptin.[online]Available at:http://www.nhs.uk/conditions/herceptin/Pages/Introduction.aspx[Accessed 25 November 2014]&amp;lt;/ref&amp;gt;&amp;amp;nbsp;Herceptin attaches itself to the HER2 receptors on the surface of cancer cells; therefore blocking these [[Cell|cells]] from any growth signals they may have otherwise received. After this attachment, herceptin causes the [[Immune system|immune system]] to kill the cancer cells that it is attached to.&amp;amp;nbsp;&amp;lt;ref&amp;gt;Breast Cancer Care,2014,Herceptin[online]Available at:https://www.breastcancercare.org.uk/breast-cancer-information/treating-breast-cancer/targeted-therapy/trastuzumab-herceptin[Accessed 25 November 2014]&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;References&amp;lt;/u&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;&amp;lt;/u&amp;gt;&amp;lt;references /&amp;gt;&amp;lt;u&amp;gt;&amp;lt;/u&amp;gt;&lt;/div&gt;</summary>
		<author><name>130300885</name></author>
	</entry>
</feed>